End-of-day quote
Other stock markets
|
||
- EUR | - |
05-10 | Laboratorio Reig Jofre, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-13 | Transcript : Laboratorio Reig Jofre, S.A., 2023 Earnings Call, Mar 13, 2024 |
Sales 2024 * | 349M 380M 519M | Sales 2025 * | 379M 413M 565M | Capitalization | 217M 236M 323M |
---|---|---|---|---|---|
Net income 2024 * | 11M 11.99M 16.39M | Net income 2025 * | 14M 15.26M 20.86M | EV / Sales 2024 * | 0.73 x |
Net Debt 2024 * | 39.5M 43.04M 58.86M | Net Debt 2025 * | 33.3M 36.29M 49.62M | EV / Sales 2025 * | 0.66 x |
P/E ratio 2024 * |
19.3
x | P/E ratio 2025 * |
15
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 21.19% |
Latest transcript on Laboratorio Reig Jofre SA
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | 05-12-31 | |
Carmen Esclapés
CTO | Chief Tech/Sci/R&D Officer | - | 02-12-31 |
Chief Operating Officer | 52 | 02-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | 05-12-31 | |
Director/Board Member | - | 14-12-30 | |
Director/Board Member | - | 14-12-30 |
1st Jan change | Capi. | |
---|---|---|
+61.71% | 856B | |
+38.95% | 631B | |
-3.92% | 359B | |
+15.46% | 325B | |
+9.10% | 297B | |
+5.89% | 234B | |
+16.53% | 226B | |
+16.07% | 177B | |
+2.19% | 165B |